Transcription of Multiple myeloma – lenalidomide Initial PBS authority ...
{{id}} {{{paragraph}}}
1 of 4 Multiple myeloma lenalidomideInitial PBS authority applicationand supporting informationPurpose of this formYou must lodge this form for a patient starting Initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with lenalidomide for Multiple applications must be in writing and must include sufficient information to determine the patient s eligibility according to the PBS assessments, pathology tests and diagnostic imaging studies must be made within 1 month of the date of application unless otherwise information on this form is correct at the time of publishing and is subject to 100 arrangementsThis item is only available to a patient who is attending.
4203.1209 3 of 4 and has a histological diagnosis of multiple myeloma (Note: Diagnostic bone marrow must be supplied)and has failed a trial of at least 4 weeks of thalidomide treatment at …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}